Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2011 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Asset Utilization Ratio came in at 1.38 in Q2 2026, up 58.64% on a YoY basis from 0.87 in Q2 2025, and up 20.93% quarter-over-quarter from 1.14 in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Asset Utilization Ratio for 11 consecutive years, with 1.38 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio rose 58.64% year-over-year to 1.38; the trailing twelve-month figure through Jun 2026 stood at 1.38 (up 58.64% YoY), and the FY2025 full-year result was 1.13, up 119.63% from the prior year.
- Asset Utilization Ratio grew to 1.38 in Q2 2026 per NMTC's latest filing, from 1.14 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.38 in Q2 2026 and bottomed at 0.01 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.57 across 5 years, with a median of 0.67 in 2024.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio tumbled 30.1% in 2022, then jumped 1908.19% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.02 in 2022, then soared by 1704.59% to 0.4 in 2023, then soared by 139.58% to 0.97 in 2024, then fell by 7.11% to 0.9 in 2025, then soared by 52.93% to 1.38 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.38, 1.14, and 0.9 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.42 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 0.54 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 0.40 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 0.55 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.47 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.48 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.34 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 0.76 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 0.56 |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn | 1.38 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 |
| Mar 31, 2026 | 1.14 |
| Dec 31, 2025 | 0.90 |
| Sep 30, 2025 | 0.84 |
| Jun 30, 2025 | 0.87 |
| Mar 31, 2025 | 1.05 |
| Dec 31, 2024 | 0.97 |
| Sep 30, 2024 | 0.67 |
| Jun 30, 2024 | 0.76 |
| Mar 31, 2024 | 0.66 |
| Dec 31, 2023 | 0.40 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.02 |